Funded startups/Chronicle Bio, Inc.
CB

Chronicle Bio, Inc.

SEC filing
Other Technology · Menlo Park, CA
Form D on EDGAR
Amount raised$10.3Msold at filing
Total offering$15M$4.7M still open
Investors in the raise38count reported to the SEC
FiledJul 7, 2026first sale Sep 30, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Fidji SimoDirector
Rohit GuptaExecutive Officer, Director
Jay SantoroDirector
Rishi ReddyExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
D/AJul 7, 2026$10.3M$15MEDGAR
D/AJan 7, 2026$5.4M$7MEDGAR
D/ANov 17, 2025$3.2M$5MEDGAR
DOct 15, 2025$2.2M$3MEDGAR